Beijing Controls Nearly All US Generic Drugs, Washington Must First Diversify Supply Chain to End China Reliance: Dr. Scott Atlas

While both the U.S. and Taiwan’s tensions with China seem to grow by the week, the United States is still grappling with drug shortages.

Senators on Wednesday urged a speedy shift of the nation’s medical supply chain away from the communist country. They said it would help prevent further drug shortages. NTD spoke with Dr. Scott Atlas, a senior fellow at Stanford University’s Hoover Institution and a former adviser to the White House Coronavirus Task Force, for his perspective.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.